Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the long-term efficacy and safety of entecavir 1.0
mg/d + adefovir 10 mg/d with entecavir 0.5 mg/d + adefovir 10 mg/d for chronic hepatitis B
patients with inadequate response to NUC therapy
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborator:
Major Science and Technology Special Project of China Eleventh Five-year